[go: up one dir, main page]

FI956299L - 8-okso-5,8-dihydro-6H-dibentso(a,g)kinolitsiini-13-propaanihappojohdannaisia, niiden valmistus ja niiden käyttö terapiassa - Google Patents

8-okso-5,8-dihydro-6H-dibentso(a,g)kinolitsiini-13-propaanihappojohdannaisia, niiden valmistus ja niiden käyttö terapiassa Download PDF

Info

Publication number
FI956299L
FI956299L FI956299A FI956299A FI956299L FI 956299 L FI956299 L FI 956299L FI 956299 A FI956299 A FI 956299A FI 956299 A FI956299 A FI 956299A FI 956299 L FI956299 L FI 956299L
Authority
FI
Finland
Prior art keywords
quinolizine
dibenzo
dihydro
oxo
therapy
Prior art date
Application number
FI956299A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI956299A7 (fi
FI956299A0 (fi
Inventor
Benoit Marabout
Mireille Sevrin
Jacques Froissant
Emmanuelle Dachary
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI956299A0 publication Critical patent/FI956299A0/fi
Publication of FI956299A7 publication Critical patent/FI956299A7/fi
Publication of FI956299L publication Critical patent/FI956299L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI956299A 1994-12-29 1995-12-28 8-okso-5,8-dihydro-6H-dibentso(a,g)kinolitsiini-13-propaanihappojohdannaisia, niiden valmistus ja niiden käyttö terapiassa FI956299L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415836A FR2728902B1 (fr) 1994-12-29 1994-12-29 Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
FI956299A0 FI956299A0 (fi) 1995-12-28
FI956299A7 FI956299A7 (fi) 1996-06-30
FI956299L true FI956299L (fi) 1996-06-30

Family

ID=9470389

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956299A FI956299L (fi) 1994-12-29 1995-12-28 8-okso-5,8-dihydro-6H-dibentso(a,g)kinolitsiini-13-propaanihappojohdannaisia, niiden valmistus ja niiden käyttö terapiassa

Country Status (26)

Country Link
US (1) US5614517A (zh)
EP (1) EP0719776B1 (zh)
JP (1) JPH08239383A (zh)
KR (1) KR960022518A (zh)
CN (1) CN1058009C (zh)
AR (1) AR002015A1 (zh)
AT (1) ATE172973T1 (zh)
AU (1) AU697988B2 (zh)
BR (1) BR9506105A (zh)
CA (1) CA2166233A1 (zh)
CO (1) CO4700297A1 (zh)
CZ (1) CZ348895A3 (zh)
DE (1) DE69505781T2 (zh)
DK (1) DK0719776T3 (zh)
ES (1) ES2126232T3 (zh)
FI (1) FI956299L (zh)
FR (1) FR2728902B1 (zh)
HU (1) HU215393B (zh)
IL (1) IL116596A (zh)
NO (1) NO305084B1 (zh)
NZ (1) NZ280766A (zh)
PL (1) PL181811B1 (zh)
RU (1) RU2155764C2 (zh)
SK (1) SK280546B6 (zh)
TW (1) TW385311B (zh)
ZA (1) ZA9511035B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806723B1 (fr) * 2000-03-23 2002-05-10 Sanofi Synthelabo DERIVES D'ACIDE 8-OXO-5,8-DIHYDRO-6H-DIBENZO [a,g] QUINOLIZINE-13-PROPANOIQUE , LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
CN104127414B (zh) * 2013-05-03 2018-04-13 中国科学院上海药物研究所 一种六氢二苯并[a,g]喹嗪类化合物的药物用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013616A (en) * 1971-11-22 1977-03-22 Wallace Richard A Mixed polymeric structural material and method
FR2537583B1 (fr) * 1982-12-14 1985-08-09 Urpha Enantiomeres levogyres des derives de la tetrahydro-5, 6, 13, 13a 8h-dibenzo (a,g-) quinolizine, procedes d'obtention, compositions pharmaceutiques les contenant et application
GB8429710D0 (en) * 1984-11-23 1985-01-03 Fujisawa Pharmaceutical Co Pharmaceutical composition
JPS61130289A (ja) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd 13−プロピルベルベリンの塩
HU195505B (en) * 1985-05-24 1988-05-30 Chinoin Gyogyszer Es Vegyeszet Process for producing 7,8-methylendioxy-14-hydroxy-berban derivatives and pharmaceuticals comprising the same

Also Published As

Publication number Publication date
ATE172973T1 (de) 1998-11-15
RU2155764C2 (ru) 2000-09-10
KR960022518A (ko) 1996-07-18
HUT74186A (en) 1996-11-28
DE69505781T2 (de) 1999-06-17
EP0719776A1 (fr) 1996-07-03
DE69505781D1 (de) 1998-12-10
PL312080A1 (en) 1996-07-08
NO955325L (no) 1996-07-01
HU215393B (hu) 1998-12-28
IL116596A0 (en) 1996-03-31
HU9503846D0 (en) 1996-02-28
AU4070895A (en) 1996-07-04
SK280546B6 (sk) 2000-03-13
CN1131154A (zh) 1996-09-18
CA2166233A1 (en) 1996-06-30
AR002015A1 (es) 1998-01-07
NO955325D0 (no) 1995-12-28
IL116596A (en) 1998-10-30
FI956299A7 (fi) 1996-06-30
TW385311B (en) 2000-03-21
CO4700297A1 (es) 1998-12-29
NO305084B1 (no) 1999-03-29
CZ348895A3 (en) 1996-07-17
US5614517A (en) 1997-03-25
BR9506105A (pt) 1997-12-23
ES2126232T3 (es) 1999-03-16
CN1058009C (zh) 2000-11-01
NZ280766A (en) 1996-09-25
DK0719776T3 (da) 1999-07-19
FR2728902B1 (fr) 1997-01-31
EP0719776B1 (fr) 1998-11-04
FR2728902A1 (fr) 1996-07-05
ZA9511035B (en) 1996-07-01
FI956299A0 (fi) 1995-12-28
PL181811B1 (pl) 2001-09-28
AU697988B2 (en) 1998-10-22
SK165895A3 (en) 1996-07-03
JPH08239383A (ja) 1996-09-17

Similar Documents

Publication Publication Date Title
FI971529L (fi) Uudet karboksyylihappojohdannaiset, niiden valmistus ja käyttö
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI934220A7 (fi) Piperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
EE9700039A (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
FI955248A7 (fi) 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö
FI962927A7 (fi) Tetrasykliinijohdannaisia, valmistusmenetelmä ja käyttö
FI954763A7 (fi) Oksiinijohdannaiset, niiden valmistus ja niiden terapeuttinen käyttö
FI944600L (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI914611A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
FI913067A7 (fi) Bisfosfonihappojohdannaiset, niiden valmistus ja käyttö
FI922982A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI934221A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI921814A7 (fi) 2-aminopyrimidiini-4-karboksiamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI920663A7 (fi) Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö
FI956299A7 (fi) 8-okso-5,8-dihydro-6H-dibentso(a,g)kinolitsiini-13-propaanihappojohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI895286A7 (fi) Fenyylioksipropanoliamineja, niiden valmistus ja terapeuttinen käyttö
FI954141L (fi) Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
FI965172A7 (fi) Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö
FI894758A7 (fi) 3-Aryylioksimetyyli-kefalosporiinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö
FI922980A7 (fi) 2-piperidinyylipyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI941650L (fi) Uudet fluorikinolin-3-karboksyylihappojohdannaiset ja niiden valmistus